McAdam LLC’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$384K Buy
4,479
+127
+3% +$12.4K 0.01% 336
2026
Q2
$450K Buy
4,352
+555
+15% +$49.5K 0.02% 292
2026
Q1
$273K Buy
3,797
+194
+5% +$14.9K 0.01% 361
2025
Q4
$286K Buy
3,603
+771
+27% +$60.8K 0.01% 333
2025
Q3
$214K Buy
+2,832
New +$194K 0.01% 374
2024
Q4
– Sell
-4,354
Closed -$274K – 358
2024
Q3
$274K Buy
+4,354
New +$254K 0.02% 274
2020
Q2
– Sell
-3,885
Closed -$231K – 128
2020
Q1
$231K Sell
3,885
-183
-4% -$12.2K 0.06% 90
2019
Q4
$302K Buy
4,068
+699
+21% +$49.1K 0.07% 60
2019
Q3
$213K Buy
+3,369
New +$200K 0.06% 74
2019
Q2
– Sell
-5,342
Closed -$288K – 76
2019
Q1
$288K Buy
+5,342
New +$330K 0.1% 53
2018
Q4
– Sell
-2
Closed – – 167
2018
Q3
$0 Hold
2
– – ﹤0.01% 672
2018
Q2
$0 Sell
2
-53
-96% -$3.49K ﹤0.01% 669
2018
Q1
$3K Buy
+55
New +$3.95K ﹤0.01% 462

Other funds holding CVS

McAdam LLC's CVS Position: Q3 2026 in Review

McAdam LLC increased its CVS Health (CVS) stake by 2.9% in Q3 2026, buying an estimated $12.4K and bringing the position to 4,479 shares worth $384K. The position accounts for 0.01% of the portfolio, ranked #336.

McAdam LLC first reported a position in CVS in Q1 2018 and has held it in 13 quarters since. The position peaked at $450K in Q2 2026. 557 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • McAdam LLC held 4,479 shares of CVS Health worth $384K as of Q3 2026.
  • McAdam LLC bought 127 CVS Health shares in Q3 2026, an estimated $12.4K.
  • CVS Health made up 0.01% of McAdam LLC's portfolio in Q3 2026, its #336 holding.
  • McAdam LLC first reported a position in CVS Health in Q1 2018 and has held it in 13 quarters since.
  • McAdam LLC's CVS Health position peaked at $450K in Q2 2026.
  • 557 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on McAdam LLC's 13F filing for Q3 2026, filed 21 Oct 2026.